Ads
related to: gilenya multiple sclerosis treatment- Copay Program
Explore Important Financial And
Copay Information.
- Financial Support
Understand Financial & Insurance
Support For Your Treatment.
- How VUMERITY® Works
Learn More About How
VUMERITY® Is Thought To Work.
- VUMERITY® Support Program
Join The Support Program To Receive
Tips, Tools And Assistance.
- Resources for Care
Partners. Explore
RMS Articles, Tools & Advice.
- Consider Switching
Considering Switching? Find Out
if VUMERITY® Could Work For You.
- Copay Program
Search results
Is Biogen a Smart Biotech Stock to Buy Right Now?
Motley Fool· 2 years agoTens of millions of Alzheimer's disease patients were given a rare dose of good news recently when Biogen (NASDAQ: BIIB) released some encouraging...
How Novartis' Laggard Business Was Its Second-Quarter Saving Grace
Investor's Business Daily· 2 years agoSwiss drugmaker Novartis delivered a mixed second-quarter report Tuesday, but Novartis stock popped...
Novartis Breaks Out After Putting Up Its Best Profit Growth In Two Years
Investor's Business Daily· 10 months agoNovartis stock broke out Tuesday after the Big Pharma stalwart put up its best profit growth in two...
Novartis Planning to Bring Dispute Over Drug Patent to U.S. Supreme Court
Investing.com via Yahoo Finance· 2 years agoBy Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) says it plans to petition the U.S. Supreme Court to uphold the validity of its patent for a dosing regimen of its blockbuster multiple ...
Novartis, helped by cost cuts, raises full-year outlook
Reuters via Yahoo Finance· 1 year agoFRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings outlook following cost cuts,...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 2 weeks agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Novartis (NVS) Q4 Earnings Miss on Higher Costs, Sales Lag
Zacks via Yahoo Finance· 3 months agoSwiss pharma giant Novartis AG NVS reported lower-than-expected results in the fourth quarter of...
Ads
related to: gilenya multiple sclerosis treatment